Patere Shilpa N, Saraf Madhusudan N, Majumdar Anuradha S
Department of Pharmacology, Bombay College of Pharmacy, Kalina, Mumbai, India.
Basic Clin Pharmacol Toxicol. 2009 Sep;105(3):173-80. doi: 10.1111/j.1742-7843.2009.00418.x. Epub 2009 Apr 16.
In recent years, oxidative stress has been implicated in the pathophysiology of a large number of diseases or disorders which are initiated and/or exacerbated by pro-oxidants such as various drugs including alcohol and food additives. The present study was carried out to evaluate the effects of oral treatment with polyherbal formulation Normeta (2 ml and 4 ml/kg) on hepatic damage induced by alcohol 10-30% (blood alcohol was maintained at levels between 150 and 350 mg/dl), thermally oxidized oil (polyunsaturated fatty acids) (15% of diet) and carbonyl iron (1.5-2% of diet) for 30 days in rats. In vitro studies with 1, 1-Diphenyl, 2-Picrylhydrazyl (DPPH), Nitric oxide and Ferric chloride (Fe(+3) ions) showed that Normeta possesses antioxidant and metal chelating activity. Alcohol, polyunsaturated fatty acids and iron feeding produced an increase in serum levels of iron, serum glutamate pyruvate transaminase and decrease in serum proteins. It was also associated with elevated lipid peroxidation (thiobarbituric acid reactive substances) and disruption of antioxidant defence mechanism in liver, decreased body weight and increased liver to body weight ratio. Oral administration of Normeta along with alcohol, polyunsaturated fatty acids and iron decreased the serum iron, serum glutamate pyruvate transaminase levels and increased serum protein levels. The levels of liver thiobarbituric acid reactive substances were decreased and the activities of antioxidant enzymes superoxide dismutase and catalase were increased. Improvement in body weight and liver to body weight ratio was also observed. The effects of Normeta on physico-metabolic parameters were comparable with silymarin. This indicates that Normeta has favourable effect in bringing down the severity of hepatotoxicity.
近年来,氧化应激与大量疾病或病症的病理生理学相关,这些疾病或病症由促氧化剂引发和/或加剧,促氧化剂包括各种药物,如酒精和食品添加剂。本研究旨在评估口服多草药配方Normeta(2毫升/千克和4毫升/千克)对大鼠肝脏损伤的影响,该损伤由10 - 30%的酒精(血液酒精浓度维持在150至350毫克/分升之间)、热氧化油(多不饱和脂肪酸)(占饮食的15%)和羰基铁(占饮食的1.5 - 2%)诱导,持续30天。用1,1 - 二苯基 - 2 - 苦基肼(DPPH)、一氧化氮和氯化铁(Fe(+3)离子)进行的体外研究表明,Normeta具有抗氧化和金属螯合活性。喂食酒精、多不饱和脂肪酸和铁会导致血清铁水平、血清谷氨酸丙酮酸转氨酶升高,血清蛋白降低。它还与肝脏脂质过氧化(硫代巴比妥酸反应性物质)升高、抗氧化防御机制破坏、体重减轻以及肝脏与体重比增加有关。口服Normeta与酒精、多不饱和脂肪酸和铁一起可降低血清铁、血清谷氨酸丙酮酸转氨酶水平,并提高血清蛋白水平。肝脏硫代巴比妥酸反应性物质水平降低,抗氧化酶超氧化物歧化酶和过氧化氢酶的活性增加。还观察到体重以及肝脏与体重比有所改善。Normeta对生理代谢参数的影响与水飞蓟宾相当。这表明Normeta在降低肝毒性严重程度方面具有有益作用。